GlassScriptPhysician profile
Ali S Khan
NPI 1235332321
$48,750.13
in general payments reported to CMS, 2019-2025
11 companies · $6,077 in 2025
The $6,077 reported for 2025 was more than what 91% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,523 · 2020: $7,727 · 2021: $10K · 2022: $3,346 · 2023: $8,855 · 2024: $11K · 2025: $6,077.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Travel and Lodging: $2,205 · Food and Beverage: $2,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,750.00 |
| Travel and Lodging | $2,205.28 |
| Food and Beverage | $2,092.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $43,634.41 | 2020-2025 | |
| Olympus Corporation of The Americas | $2,221.78 | 2023-2025 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655, Olympus |
| Boston Scientific Corporation | $1,112.72 | 2019-2023 | Acquire, Exalt Model D |
| Apollo Endosurgery US INC | $700.77 | 2019-2022 | |
| Medtronic, INC. | $532.54 | 2024-2025 | Gi Genius, Dragonfly Pancreaticobiliary Scope and Instrument Channel Caps, Manoscan |
| Olympus America INC. | $250.31 | 2019-2023 | Hanarostent Lowaxtm Duodenum/Pylorus(Nnn) |
| Steris Corporation | $123.20 | 2023 | |
| Mauna Kea Technologies, INC. | $54.02 | 2019 | |
| Erbe USA INC | $50.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $45.46 | 2022 | |
| Endogastric Solutions, INC | $24.92 | 2024 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.